SSII

SS Innovations International

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
MCAP MediaWire
7 hours ago
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Strong growth in SSi Mantra installations, procedures and revenues Fort Lauderdale, FL, March 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Neutral
GlobeNewsWire
7 hours ago
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
FORT LAUDERDALE, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and twelve months ended December 31, 2025.
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Neutral
MCAP MediaWire
yesterday
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
Financing led by Certain of the Company's Directors and Executive Officers Fort Lauderdale, FL, March 9, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
Neutral
GlobeNewsWire
yesterday
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
FORT LAUDERDALE, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that on March 6, 2026, the Company completed a private placement of its common stock (the “Private Placement”) which generated approximately $18.6 million in gross proceeds, before deducting offering expenses.
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
Neutral
MCAP MediaWire
1 month ago
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic system Fort Lauderdale, FL, January 13, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
Neutral
GlobeNewsWire
1 month ago
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
FORT LAUDERDALE, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced preliminary unaudited revenue and other select operating metrics for the three and twelve months ended December 31, 2025.
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
Neutral
MCAP MediaWire
2 months ago
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
Fort Lauderdale, FL, January 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Milan Rao as the Company's Global Chief Operating Officer and Chief Financial Officer.
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
Neutral
GlobeNewsWire
2 months ago
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
FORT LAUDERDALE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Milan Rao as the Company's Global Chief Operating Officer and Chief Financial Officer.
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
Neutral
MCAP MediaWire
2 months ago
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets
Smaller 5-millimeter instruments to be incorporated into the SSi Mantra surgical robotic system Takeways: Fort Lauderdale, FL, January 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets
Neutral
GlobeNewsWire
2 months ago
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets
FORT LAUDERDALE, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has completed the development of five new 5-millimeter surgical instruments for clinical use across multiple specialties, including pediatric, cardiac, and head and neck surgery, among other procedures involving smaller anatomical structures.
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets